86364754 - SOCTEC

Information

• Trademark
• 86364754

• Source

• Serial Number

  86364754

• Registration Number

  5494819

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 12, 2014
  10 years ago

• Registration Date

  June 19, 2018
  6 years ago

• Transaction Date

  August 29, 2024
  2 months ago

• Status Date

  June 19, 2018
  6 years ago

• Published for Opposition Date

  April 03, 2018
  6 years ago

• Location Date

  June 19, 2018
  6 years ago

• Status Code

  700

• Current Location

  TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  HENRY, NAKIA D

• Attorney Docket Number

  REGI-0002

  Attorney Name

  Molly Buck Richard

  Law Office Assigned Location Code

  O20

• Owners

  • Jagotec AG

Case File Statements

• GS0051: Pharmaceuticals having a self-orienting effect, namely, orally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsules, namely, capsules consisting of segments of varied functions and absorption rates, resulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medical, surgical and biological purposes; chronotherapy-focused tablets, analgesics; Medicines for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders, medical and veterinary preparations for body slimming purposes; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents; exclude goods being related to the treatment of respiratory diseases
• TR0010: The word(s) "SOCTEC" has no meaning in a foreign language.
• GS0441: Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medical, surgical and veterinary matters online from a computer database or over the Internet; exclude services in the field of inhalation technology
• GS0101: inhalers for medical purposes; injection apparatus, instruments and devices, namely, medical apparatus in the nature of an infusion injection device for administering drugs; apparatus, instruments and devices, namely, automated drug delivery systems for storing and dispensing medical, surgical and veterinary preparations, capsules, powders, tablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substances, namely, gastrointestinal drug delivery systems, syringes and fluid injectors for medical purposes; exclude goods being related to the treatment of respiratory diseases
• GS0421: Scientific and technological services, namely, custom design exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods; exclude services in the field of inhalation technology

Case File Event Statements

• 8/15/2014 - 10 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 8/21/2014 - 10 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/25/2014 - 10 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/26/2014 - 10 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/26/2014 - 10 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/26/2014 - 10 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/26/2015 - 9 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/1/2015 - 9 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 6/8/2015 - 9 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/8/2015 - 9 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/25/2015 - 9 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 6/25/2015 - 9 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/25/2015 - 9 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 12/29/2015 - 8 years ago

  14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 1/20/2016 - 8 years ago

  15 - SUSPENSION LETTER WRITTEN Type: CNSL

• 1/20/2016 - 8 years ago

  17 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 1/20/2016 - 8 years ago

  16 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 7/14/2016 - 8 years ago

  18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 7/14/2016 - 8 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/14/2016 - 8 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/20/2016 - 8 years ago

  21 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 8/15/2016 - 8 years ago

  22 - PRIORITY ACTION WRITTEN Type: CPRA

• 8/15/2016 - 8 years ago

  24 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 8/15/2016 - 8 years ago

  23 - PRIORITY ACTION E-MAILED Type: GPRA

• 1/31/2017 - 7 years ago

  25 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/31/2017 - 7 years ago

  27 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/31/2017 - 7 years ago

  26 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/31/2017 - 7 years ago

  28 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/31/2017 - 7 years ago

  29 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/7/2017 - 7 years ago

  30 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 2/22/2017 - 7 years ago

  31 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/14/2017 - 7 years ago

  32 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/14/2017 - 7 years ago

  33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/9/2017 - 7 years ago

  34 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/31/2017 - 7 years ago

  37 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 10/31/2017 - 7 years ago

  35 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 10/31/2017 - 7 years ago

  36 - CASE RETURNED TO EXAMINATION Type: OTHE

• 10/31/2017 - 7 years ago

  38 - SUSPENSION LETTER WRITTEN Type: CNSL

• 10/31/2017 - 7 years ago

  40 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 10/31/2017 - 7 years ago

  39 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 11/2/2017 - 7 years ago

  41 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 11/3/2017 - 7 years ago

  43 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/3/2017 - 7 years ago

  42 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/27/2017 - 6 years ago

  44 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/27/2017 - 6 years ago

  46 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/27/2017 - 6 years ago

  45 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/12/2018 - 6 years ago

  47 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/12/2018 - 6 years ago

  48 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/12/2018 - 6 years ago

  49 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/13/2018 - 6 years ago

  50 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/13/2018 - 6 years ago

  51 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/26/2018 - 6 years ago

  52 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 3/14/2018 - 6 years ago

  53 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/3/2018 - 6 years ago

  54 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/3/2018 - 6 years ago

  55 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/29/2018 - 6 years ago

  56 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/19/2018 - 6 years ago

  57 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/19/2023 - a year ago

  58 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 8/22/2024 - 3 months ago

  59 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 8/29/2024 - 2 months ago

  60 - TEAS SECTION 8 & 15 RECEIVED Type: E815